Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
Lonial, Sagar, Dimopoulos, Meletios, Palumbo, Antonio, White, Darrell, Grosicki, Sebastian, Spicka, Ivan, Walter-Croneck, Adam, Moreau, Philippe, Mateos, Maria-Victoria, Magen, Hila, Belch, Andrew, Reece, Donna, Beksac, Meral, Spencer, Andrew, Oakervee, Heather, Orlowski, Robert Z, Taniwaki, Masafumi, Röllig, Christoph, Einsele, Hermann, Wu, Ka Lung, Singhal, Anil, San-Miguel, Jesus, Matsumoto, Morio, Katz, Jessica, Bleickardt, Eric, Poulart, Valerie, Anderson, Kenneth C, Richardson, Paul
Published in The New England journal of medicine (13.08.2015)
Published in The New England journal of medicine (13.08.2015)
Get full text
Journal Article
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
Jakubowiak, Andrzej, Offidani, Massimo, Pégourie, Brigitte, De La Rubia, Javier, Garderet, Laurent, Laribi, Kamel, Bosi, Alberto, Marasca, Roberto, Laubach, Jacob, Mohrbacher, Ann, Carella, Angelo Michele, Singhal, Anil K., Tsao, L.Claire, Lynch, Mark, Bleickardt, Eric, Jou, Ying-Ming, Robbins, Michael, Palumbo, Antonio
Published in Blood (09.06.2016)
Published in Blood (09.06.2016)
Get full text
Journal Article
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Kantarjian, Hagop, Shah, Neil P, Shah, Sandip, Hochhaus, Andreas, Cortes, Jorge, Ayala, Manuel, Moiraghi, Beatriz, Shen, Zhixiang, Mayer, Jiri, Pasquini, Ricardo, Nakamae, Hirohisa, Huguet, Françoise, Boqué, Concepción, Chuah, Charles, Bleickardt, Eric, Bradley-Garelik, M. Brigid, Zhu, Chao, Szatrowski, Ted, Shapiro, David, Baccarani, Michele
Published in The New England journal of medicine (17.06.2010)
Published in The New England journal of medicine (17.06.2010)
Get full text
Journal Article
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma
Pasquini, Marcelo C., Hu, Zhen-Huan, Curran, Kevin, Laetsch, Theodore, Locke, Frederick, Rouce, Rayne, Pulsipher, Michael A., Phillips, Christine L., Keating, Amy, Frigault, Matthew J., Salzberg, Dana, Jaglowski, Samantha, Sasine, Joshua P., Rosenthal, Joseph, Ghosh, Monalisa, Landsburg, Daniel, Margossian, Steven, Martin, Paul L., Kamdar, Manali K., Hematti, Peiman, Nikiforow, Sarah, Turtle, Cameron, Perales, Miguel-Angel, Steinert, Patricia, Horowitz, Mary M., Moskop, Amy, Pacaud, Lida, Yi, Lan, Chawla, Raghav, Bleickardt, Eric, Grupp, Stephan
Published in Blood advances (10.11.2020)
Published in Blood advances (10.11.2020)
Get full text
Journal Article
Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis
Shah, Neil P., Kasap, Corynn, Weier, Christopher, Balbas, Minna, Nicoll, John M., Bleickardt, Eric, Nicaise, Claude, Sawyers, Charles L.
Published in Cancer cell (09.12.2008)
Published in Cancer cell (09.12.2008)
Get full text
Journal Article
Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
SHAH, Neil P, KANTARJIAN, Hagop M, KHOROSHKO, Nina, PAQUETTE, Ronald L, DEININGER, Michael, COLLINS, Robert H, OTERO, Irma, HUGHES, Timothy, BLEICKARDT, Eric, STRAUSS, Lewis, FRANCIS, Stephen, HOCHHAUS, Andreas, KIM, Dong-Wook, REA, Delphine, DORLHIAC-LLACER, Pedro E, MILONE, Jorge H, VELA-OJEDA, Jorge, SILVER, Richard T, KHOURY, H. Jean, CHARBONNIER, Aude
Published in Journal of clinical oncology (01.07.2008)
Published in Journal of clinical oncology (01.07.2008)
Get full text
Journal Article
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study
Richardson, Paul G, Jagannath, Sundar, Moreau, Philippe, Jakubowiak, Andrzej J, Raab, Marc S, Facon, Thierry, Vij, Ravi, White, Darrell, Reece, Donna E, Benboubker, Lotfi, Zonder, Jeffrey, Tsao, L Claire, Anderson, Kenneth C, Bleickardt, Eric, Singhal, Anil K, Lonial, Sagar
Published in The Lancet. Haematology (01.12.2015)
Published in The Lancet. Haematology (01.12.2015)
Get more information
Journal Article
Elotuzumab with lenalidomide and dexamethasone for Japanese patients with relapsed/refractory multiple myeloma: phase 1 study
Iida, Shinsuke, Nagai, Hirokazu, Kinoshita, Gen, Miyoshi, Masafumi, Robbins, Michael, Pandya, Dimple, Bleickardt, Eric, Chou, Takaaki
Published in International journal of hematology (01.03.2017)
Published in International journal of hematology (01.03.2017)
Get full text
Journal Article
Dasatinib or high‐dose imatinib for chronic‐phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily
Kantarjian, Hagop, Pasquini, Ricardo, Lévy, Vincent, Jootar, Saengsuree, Holowiecki, Jerzy, Hamerschlak, Nelson, Hughes, Timothy, Bleickardt, Eric, Dejardin, David, Cortes, Jorge, Shah, Neil P.
Published in Cancer (15.09.2009)
Published in Cancer (15.09.2009)
Get full text
Journal Article
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth
Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Palumbo, Antonio, San‐Miguel, Jesus, Shpilberg, Ofer, Anderson, Kenneth, Grosicki, Sebastian, Spicka, Ivan, Walter‐Croneck, Adam, Magen, Hila, Mateos, Maria‐Victoria, Belch, Andrew, Reece, Donna, Beksac, Meral, Bleickardt, Eric, Poulart, Valerie, Sheng, Jennifer, Sy, Oumar, Katz, Jessica, Singhal, Anil, Richardson, Paul
Published in British journal of haematology (01.09.2017)
Published in British journal of haematology (01.09.2017)
Get full text
Journal Article
Dasatinib or High-Dose Imatinib for Chronic-Phase Chronic Myeloid Leukemia Resistant to Imatinib at a Dose of 400 to 600 Milligrams Daily: Two-Year Follow-Up of a Randomized Phase 2 Study (START-R)
KANTARJIAN, Hagop, PASQUINI, Ricardo, SHAH, Neil P, LEVY, Vincent, JOOTAR, Saengsuree, HOLOWIECKI, Jerzy, HAMERSCHLAK, Nelson, HUGHES, Timothy, BLEICKARDT, Eric, DEJARDIN, David, CORTES, Jorge
Published in Cancer (15.09.2009)
Published in Cancer (15.09.2009)
Get full text
Journal Article
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Pearson, Andrew Dj, Rossig, Claudia, Mackall, Crystal, Shah, Nirali N, Baruchel, Andre, Reaman, Gregory, Ricafort, Rosanna, Heenen, Delphine, Bassan, Abraham, Berntgen, Michael, Bird, Nick, Bleickardt, Eric, Bouchkouj, Najat, Bross, Peter, Brownstein, Carrie, Cohen, Sarah Beaussant, de Rojas, Teresa, Ehrlich, Lori, Fox, Elizabeth, Gottschalk, Stephen, Hanssens, Linda, Hawkins, Douglas S, Horak, Ivan D, Taylor, Danielle H, Johnson, Courtney, Karres, Dominik, Ligas, Franca, Ludwinski, Donna, Mamonkin, Maksim, Marshall, Lynley, Masouleh, Behzad K, Matloub, Yousif, Maude, Shannon, McDonough, Joe, Minard-Colin, Veronique, Norga, Koen, Nysom, Karsten, Pappo, Alberto, Pearce, Laura, Pieters, Rob, Pule, Martin, Quintás-Cardama, Alfonso, Richardson, Nick, Schüßler-Lenz, Martina, Scobie, Nicole, Sersch, Martina A, Smith, Malcolm A, Sterba, Jaroslav, Tasian, Sarah K, Weigel, Brenda, Weiner, Susan L, Zwaan, Christian Michel, Lesa, Giovanni, Vassal, Gilles
Published in European journal of cancer (1990) (01.01.2022)
Published in European journal of cancer (1990) (01.01.2022)
Get full text
Journal Article
Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study
Berdeja, Jesus, Jagannath, Sundar, Zonder, Jeffrey, Badros, Ashraf, Kaufman, Jonathan L, Manges, Robert, Gupta, Manish, Tendolkar, Amol, Lynch, Mark, Bleickardt, Eric, Paliwal, Prashni, Vij, Ravi
Published in Clinical lymphoma, myeloma and leukemia (01.03.2016)
Published in Clinical lymphoma, myeloma and leukemia (01.03.2016)
Get full text
Journal Article
Elotuzumab in combination with thalidomide and low‐dose dexamethasone: a phase 2 single‐arm safety study in patients with relapsed/refractory multiple myeloma
Mateos, María‐Victoria, Granell, Miguel, Oriol, Albert, Martinez‐Lopez, Joaquin, Blade, Joan, Hernandez, Miguel T., Martín, Jesus, Gironella, Mercedes, Lynch, Mark, Bleickardt, Eric, Paliwal, Prashni, Singhal, Anil, San‐Miguel, Jesus
Published in British journal of haematology (01.11.2016)
Published in British journal of haematology (01.11.2016)
Get full text
Journal Article
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry
Jaglowski, Samantha, Hu, Zhen-Huan, Zhang, Yiyun, Kamdar, Manali, Ghosh, Monalisa, Lulla, Premal, Sasine, Joshua, Perales, Miguel-Angel, Hematti, Peiman, Nikiforow, Sarah, Steinert, Patricia, Jeschke, Margit, Yi, Lan, Chawla, Raghav, Pacaud, Lida, Horowitz, Mary M., Bleickardt, Eric, Pasquini, Marcelo C.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World Experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and Cellular Therapy (CT) Registry
Grupp, Stephan, Hu, Zhen-Huan, Zhang, Yiyun, Keating, Amy, Pulsipher, Michael A., Philips, Christine, Margossian, Steven P., Rosenthal, Joseph, Salzberg, Dana, Schiff, Deborah E., Yanik, Gregory, Curran, Kevin J., Harris, Andrew C., Hematti, Peiman, Nikiforow, Sarah, Steinert, Patricia, Yi, Lan, Chawla, Raghav, Horowitz, Mary M., Bleickardt, Eric, Pasquini, Marcelo C.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer
Pearson, Andrew DJ, Rossig, Claudia, Mackall, Crystal, Shah, Nirali N., Baruchel, Andre, Reaman, Gregory, Ricafort, Rosanna, Heenen, Delphine, Bassan, Abraham, Berntgen, Michael, Bird, Nick, Bleickardt, Eric, Bouchkouj, Najat, Bross, Peter, Brownstein, Carrie, Cohen, Sarah Beaussant, de Rojas, Teresa, Ehrlich, Lori, Fox, Elizabeth, Gottschalk, Stephen, Hanssens, Linda, Hawkins, Douglas S., Horak, Ivan D., Taylor, Danielle H., Johnson, Courtney, Karres, Dominik, Ligas, Franca, Ludwinski, Donna, Mamonkin, Maksim, Marshall, Lynley, Masouleh, Behzad K., Matloub, Yousif, Maude, Shannon, McDonough, Joe, Minard-Colin, Veronique, Norga, Koen, Nysom, Karsten, Pappo, Alberto, Pearce, Laura, Pieters, Rob, Pule, Martin, Quintás-Cardama, Alfonso, Richardson, Nick, Schüßler-Lenz, Martina, Scobie, Nicole, Sersch, Martina A., Smith, Malcolm A., Sterba, Jaroslav, Tasian, Sarah K., Weigel, Brenda, Weiner, Susan L., Zwaan, Christian Michel, Lesa, Giovanni, Vassal, Gilles
Published in European journal of cancer (1990) (01.01.2022)
Published in European journal of cancer (1990) (01.01.2022)
Get full text
Journal Article
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration2
Pearson, Andrew D J, Rossig, Claudia, Mackall, Crystal, Shah, Nirali N, Baruchel, Andre, Reaman, Gregory, Ricafort, Rosanna, Heenen, Delphine, Bassan, Abraham, Berntgen, Michael, Bird, Nick, Bleickardt, Eric, Bouchkouj, Najat, Bross, Peter, Brownstein, Carrie, Cohen, Sarah Beaussant, deRojas, Teresa, Ehrlich, Lori, Fox, Elizabeth, Gottschalk, Stephen, Hanssens, Linda, Hawkins, Douglas S, Horak, Ivan D, Taylor, Danielle H, Johnson, Courtney, Karres, Dominik, Ligas, Franca, Ludwinski, Donna, Mamonkin, Maksim, Marshall, Lynley, Masouleh, Behzad K, Matloub, Yousif, Maude, Shannon, McDonough, Joe, Minard-Colin, Veronique, Norga, Koen, Nysom, Karsten, Pappo, Alberto, Pearce, Laura, Pieters, Rob, Pule, Martin, Quintás-Cardama, Alfonso, Richardson, Nick, Schüßler-Lenz, Martina, Scobie, Nicole, Sersch, Martina A, Smith, Malcolm A, Sterba, Jaroslav, Tasian, Sarah K, Weigel, Brenda, Weiner, Susan L, Zwaan, Christian Michel, Lesa, Giovanni, Vassal, Gilles
Published in European journal of cancer (1990) (01.01.2022)
Published in European journal of cancer (1990) (01.01.2022)
Get full text
Journal Article
Abstract CT237: Evaluation of in vivo chimeric antigen receptor (CAR) transgene levels in patients (pts) treated with tisagenlecleucel
Awasthi, Rakesh, Mueller, Karen Thudium, Yanik, Gregory A., Tam, Constantine S., Rives, Susana, McGuirk, Joseph P., Pulsipher, Michael A., Boyer, Michael W., Jaeger, Ulrich, Baruchel, Andre, Myers, Gary D., Borchmann, Peter, Schuster, Stephen J., Stefanski, Heather, Bishop, Michael, Waldron, Edward R., Anak, Ozlem, Chakraborty, Abhijit, Bleickardt, Eric, Wong, Stephane, Pacaud, Lida Bubuteishvili, Waller, Edmund K., Maude, Shannon L.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract CT077: Potential utility of minimal residual disease (MRD) to identify relapse in pediatric and young adult (AYA) B-cell acute lymphoblastic leukemia (B-ALL) patients treated with tisagenlecleucel
Pulsipher, Michael A., Han, Xia, Quigley, Máire, Kari, Gabor, Rives, Susana, Laetsch, Theodore W., Myers, Gary D., Hiramatsu, Hidefumi, Yanik, Gregory A., Qayed, Muna, Driscoll, Timothy, Boyer, Michael W., Stefanski, Heather, Buchner, Jochen, Baruchel, Andre, Bader, Peter, Yi, Lan, Kalfoglou, Creton, Robins, Harlan, Yusko, Erik, Gorgun, Gullu, Bleickardt, Eric, Wong, Stephane, Grupp, Stephan A.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article